Review
Open access
Aug 2026
Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue
This review provides an overview of recent findings on curcumin-based nanocarriers for AD therapy and identifies nanocarrier-based delivery systems as a promising strategy for enhancing the bioavailability and therapeutic efficacy of curcumin.
Wushan T. Jayalath, M. J. Gunaratna, C. Kadigamuwa et al.
· Applied Biosciences · 0 citations